Worldwide: Healthcare

João Taborda da Gama continues to shape international discourse on psychedelic regulation, speaking at major European forums on the legal, ethical, and philosophical tensions surrounding controlled substances. His recent presentations in Ukraine and Portugal examine who holds authority over consciousness-altering therapies, whether existing frameworks reflect coherent principles or accumulated habit, and what risks and possibilities fall outside medicalization's reach.

Il diritto alle origini biologiche consente a ogni persona adottata di conoscere le proprie radici genetiche e familiari, ma questo diritto deve essere bilanciato con la scelta della madre biologica di mantenere l'anonimato.

Medical negligence cases occupy a difficult space in civil litigation. A patient may know that something went wrong, may have suffered a serious deterioration in health...

On March 4, 2026, Decree No. 2026-153 [1] ("Decree") was published, defining the procedures under which the Minister of Health may impose financial penalties on publishers of digital health services...

On 6 March, Law 9/2026 was published in the Official Gazette, establishing new rules applicable to clinical trials of medicinal products for human use and implementing Regulation (EU) 536/2014 in Portugal.

Every year, Belgium’s federal ministers publish their policy notes for discussion in Parliament. They give a high-level snapshot of what each minister plans to focus on in the coming year.

The Supreme Court has delivered an important judgment concerning rates exemptions (464 KB) for designated care centres operated by private providers under service arrangements with the HSE and TUSLA.

After five lean years, transactions in the healthcare market rebounded spectacularly last year.

MEPs agreed the European Parliament's negotiating position on the planned EU Critical Medicines Act (EU CMA) this week (20 January 2026), clearing the way for trilogue negotiations.